-
- Grant Support Provided by Merck
-
- Grant Support Provided by Genentech
-
- This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Activity Dates: 01/18/2012 - 12/31/2013
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care.
The goal of the Review Course is to assist the practitioner in developing and maintaining contemporary knowledge and skills at the psychiatric pharmacy specialty level. The Review Course is not designed to develop more in-depth "subspecialty" knowledge but rather allows participants to systematically review and assess their core knowledge in the psychiatric specialty practice. This course is a knowledge-based educational program designed for pharmacists to acquire factual knowledge.
The course includes:
The course examinations must be submitted by June 30, 2014.
You can preview a segment of a curriculum module and speaker presentation. Read on to learn more about this great ACPE offer and register now.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Registrants can obtain up to 20.0 contact hours of ACPE credit by successfully completing the CPNP Psychiatric Pharmacotherapy Review Course online examinations for each of the 14 topic areas included in the course. The course expires June 30, 2014.
ACPE Statements of Credit will be available online at cpnp.org upon successful completion of each examination for the 14 topic areas contained in the course. Successful completion is defined as achieving a score of 60% or higher on each examination. Notification of statement availability will be provided upon successful completion of the examination.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
2012-2013 CPNP Review Course Editorial Board
| Name | Disclosures of Interest |
|---|---|
|
Eric Kutscher, PharmD, BCPP Senior Editor Associate Professor South Dakota State University Sioux Falls, SD |
Employment: South Dakota State University-Associate Professor |
|
Cynthia Kirkwood, PharmD, BCPP BCPP Program Director Professor, Vice Chair for Education Virginia Commonwealth University Richmond, VA |
Employment: Virginia Commonwealth University- Professor of Pharmacy |
|
Douglas Boggs, PharmD, BCPP, MS Clinical Pharmacy Specialist, Psychiatry VA Connecticut Healthcare System West Haven, CT |
Employment: Clinical Pharmacy Specialist, Psychiatry Educational Grants, Research Grants or Contracts: NIDA, NIMH |
|
Megan Ehret, PharmD, BCPP Assistant Professor University of Connecticut Hartford, CT |
Employment: University of Connecticut External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Barrons PCAT Review Book Evaluator, PSAP Book Chapter Author Educational Grants, Research Grants or Contracts: American Society of Health Systems Pharmacists Research Foundation Grant |
|
Judith Hyatt, PharmD, BCPP Clinical Pharmacy Specialist, Psychiatry VA Western New York Healthcare System Adjunct Assistant Professor State University of New York at Buffalo Buffalo, NY |
Employment: VAWNY Healthcare System, Psychiatric Pharmacist External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: McGuire Group, Consultant, Peer Review Committee for the Congressionally Directed Medical Research Program (PTSD/TBI) |
|
William Klugh Kennedy, PharmD, BCPP, FASHP Clinical Associate Professor of Pharmacy Practice and Psychiatry Mercer University Savannah Campus Savannah, GA |
Employment: Mercer University, Memorial University Medical Center External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Merck Speakers Bureau-asenapine Educational Grants, Research Grants or Contracts: Research Grant JNJ-Janssen-unrestricted, investigator initiated studying paliperidone palmitate |
|
Monica Mathys, PharmD, BCPP Assistant Professor Texas Tech Health Sciences Center Dallas, TX |
Employment: Texas Tech Health Sciences Center School of Pharmacy, VA North Texas Healthcare System |
|
Brenda Schimenti, MS CPNP Executive Director Lincoln, NE |
Employment: CPNP, CPNP Foundation Board Member |
All relevant relationships have been mitigated.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
